- This event has passed.
The Era of Molecularly Targeted Cancer Therapy – An Emerging Renaissance for Nuclear Medicine?
November 7, 2018 @ 12:00 pm - 1:00 pm
Join us for our next instalment of Michener’s 60th Anniversary Lecture Series, in celebration of Medical Radiation Technologists Week, by Raymond M. Reilly, Ph.D.
Raymond Reilly is a Professor and Director of the Centre for Pharmaceutical Oncology at the Leslie Dan Faculty of Pharmacy, University of Toronto (UofT). He obtained his B.Sc. degree in pharmacy, M.Sc. degree in nuclear pharmacy and Ph.D. in medical biophysics, all at UofT. He completed a nuclear pharmacy residency at McMaster University and practiced as a nuclear pharmacist in nuclear medicine at the University Health Network prior to assuming his academic position at UofT.
Dr. Reilly’s areas of research are molecular imaging and radioimmunotherapy of cancer. He has published 160 research papers and given more than 60 presentations in this area. In 2011, a book that Dr. Reilly edited on “Monoclonal Antibody and Peptide – Targeted Radiotherapy of Cancer”, published by Wiley, won first prize in the oncology category at the British Medical Association book awards. He recently edited a second book on “Medical Imaging for Health Professionals – Technologies and Clinical Applications”, which will be published by Wiley in early 2019.
Dr. Reilly’s research is supported by the Canadian Cancer Society, Ontario Institute for Cancer Research, CIHR and NSERC. He has advanced three radiopharmaceutical agents to clinical trial from basic research in his laboratory, with a fourth agent under development for clinical translation for the treatment of HER2-positive breast cancer. He has supervised the training of more than 30 graduate students and 10 post-doctoral fellows in the radiopharmaceutical sciences. Dr. Reilly teaches an undergraduate course on medical imaging for pharmacists and a graduate course on radiopharmaceuticals at UofT.